Zoledronic acid protects against local a
✍
Petra Herrak; Birgit Görtz; Silvia Hayer; Kurt Redlich; Erika Reiter; Jürg Gasse
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 589 KB
## Abstract ## Objective Increased osteoclast activity is a key factor in bone loss in rheumatoid arthritis (RA). This suggests that osteoclast‐targeted therapies could effectively prevent skeletal damage in patients with RA. Zoledronic acid (ZA) is one of the most potent agents for blocking osteo